Contract & Agreements News

Stay updated on contracts and agreements. Read about new deals, partnerships, and significant agreements in various sectors. Discover how these contracts impact businesses, market dynamics, and industry relationships.

May 29, 2026 at 10:14 AM

Massive Bio Partners with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials

BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a global precision oncology company, today announced a new partnership with TOUCH, The Black Breast Cancer Alliance (TOUCH BBCA), a breast cancer patient advocacy organization, and Navigating Trials, a clinical trial navigation platform serving patients across all cancer types. Through this collaboration, Massive Bio's AI-powered trial matching will be made available directly within both organizations' digital platforms, giving their patient commu...
May 29, 2026 at 10:00 AM

Roberto Cavalli Global Restructuring: Marquee Brands and The Level Group Lead the Strategic Acquisition of the Italian Luxury Brand

NEW YORK--(BUSINESS WIRE)--Marquee Brands, the U.S.-based company specializing in the acquisition, management, and development of a diversified portfolio of global consumer lifestyle brands, together with The Level Group (TLG), acting as principal operating partner, have entered into a binding agreement to acquire control of the Roberto Cavalli brand as part of a complex strategic reorganization of the group. The transaction was concluded with DAMAC Group, the Dubai-based multinational conglome...
May 29, 2026 at 9:51 AM

Tanium and Censys Join Forces to Accelerate Continuous Exposure Management in the Age of AI

EMERYVILLE, Calif.--(BUSINESS WIRE)--Tanium, a leader in Autonomous IT, today announced a partnership with Censys, the authority for Internet intelligence, to deliver a unified approach to exposure management that enables organizations to continuously identify, prioritize and remediate risk across both internal and external attack surfaces. The partnership brings together Tanium’s real-time endpoint intelligence and in-platform remediation capabilities with Censys’ comprehensive, continuously u...
May 29, 2026 at 9:15 AM

DevvStream, XCF Global, and Southern Energy Renewables Confirm Three-Party Business Combination Remains on Track

CALGARY, Alberta--(BUSINESS WIRE)--DevvStream Corp. (NASDAQ: DEVS) ("DevvStream" or the "Company"), XCF Global, Inc. (NASDAQ: SAFX) ("XCF"), and Southern Energy Renewables Inc. ("Southern") (together, the "Parties") wish to clarify recent media coverage that mischaracterized a current report on Form 8-K filed by DevvStream with the U.S. Securities and Exchange Commission (the "SEC") on May 18, 2026 (the "8-K"). The 8-K reported, among other things, that DevvStream had received fairness opinions...
May 29, 2026 at 9:00 AM

Elevate Quantum, Front Range Community College, and the University of Colorado Denver Launch a Vacuum and Cryogenic Technician Training Program to Address Critical Quantum Workforce Gap Crisis

DENVER--(BUSINESS WIRE)--Elevate Quantum, today in partnership with Front Range Community College (FRCC) and University of Colorado Denver, today announced the launch of its Vacuum and Cryogenic Technician Training Program, a first-of-its-kind, specialization-focused workforce initiative housed within its commercialization lab at Quantum Commons. Elevating Quantum Upskilling through Industry Proficiencies (EQUIP) is a program designed to produce technician-ready talent capable of operating, tro...
May 29, 2026 at 9:00 AM

Zef Scientific Retains LCMS Industry Expert to Accelerate Business Expansion

LAKE FOREST, Calif.--(BUSINESS WIRE)--Zef Scientific, Inc. (ZefSci), the leading North America independent service provider of multivendor LCMS systems, today announced a partnership with Boston based Peak Life Science Advisors, LLC with industry expert Rick Carberry. Recently acquired by Shimadzu Scientific Instruments (SSI), ZefSci is looking to help fuel its growth through new partnership development within the LCMS “ecosystem”. Providing expert sales, marketing and in-lab service support fo...
May 29, 2026 at 8:15 AM

MidOcean Partners Signs Definitive Agreement to Sell Zonda to CoStar Group

NEW YORK--(BUSINESS WIRE)--MidOcean Partners (“MidOcean” or the “Firm”), a premier New York-based alternative asset manager specializing in middle market private equity, alternative credit, and structured equity, announced today the signing of the sale of Bora, Inc. and its subsidiaries (collectively, “Zonda” or the “Company”) to CoStar Group, Inc. (NASDAQ: CSGP) (“CoStar Group”). Zonda is the #1 data, marketplace, and software platform for the new home ecosystem. Zonda’s end-to-end platform sp...
May 29, 2026 at 8:00 AM

ChargePoint and Powers Parts Partner Simplify Fast Charging for Transit Operators

CAMPBELL, Calif.--(BUSINESS WIRE)--ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, and Powers Parts, a national distributor of electric and advanced mobility components, today announced a new partnership to accelerate transit electrification across North America. “Transit is critical to the broader electrification of transportation, delivering a healthier option for communities and transit riders, as well as superior experience for the drivers," said Rick...
May 29, 2026 at 6:50 AM

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to...
May 29, 2026 at 6:00 AM

Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new collaboration with Diakonos Oncology Corp., a clinical-stage biotechnology company developing immunotherapies to treat challenging and aggressive cancers. As part of the collaboration, Signatera will be used to longitudinally assess molecular response in patients with refractory melanoma enrolled in Diakonos’ DOC-RM Phase I/II investigational immunotherapy...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up